Kesin MAG-AL
NDC 81033-005, Aluminum and Magnesium Hydroxide Suspension, suspension, from Kesin Pharma Corporation.
- Product NDC
- 81033-005
- Status
- Listed
- Labeler
- Kesin Pharma Corporation
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M001
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81033-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALUMINUM HYDROXIDE200 mg/5mL
- MAGNESIUM HYDROXIDE200 mg/5mL
Pharmacologic classes
Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81033-005-01 | 81033000501 | 100 CUP, UNIT-DOSE in 1 CASE (81033-005-01) / 30 mL in 1 CUP, UNIT-DOSE (81033-005-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 81033-005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81033-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81033-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.